CAMBRIDGE, Mass. and AMSTERDAM, May 7, 2012 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a partnership with Regenesance to ...

The ALS Therapy Development Institute (ALS TDI) has developed a tool that maps ALS clinical trials globally, using technology from Esri. Dubbed ALS Trial Navigator, the tool is designed to streamline ...

Donated blood and tissue samples to be used to identify molecular signature of motor neuron disease CAMBRIDGE, Mass., Aug. 19 /PRNewswire-USNewswire/ -- ALS Therapy Development Institute (ALS TDI) ...

Chaperone Therapeutics of Research Triangle Park is teaming up with the nonprofit ALS Therapy Development Institute of Cambridge, Mass., to explore potential treatments for amyotrophic lateral ...

Program to seek much-needed new treatments for amyotrophic lateral sclerosis (Lou Gehrig's disease), currently fatal for 80 per cent within 2 to 5 years of diagnosis 1 OAKVILLE, ON, Dec. 4, 2017 /CNW/ ...

CAMBRIDGE (CBS) – The CEO of a Massachusetts ALS research organization said donations from the Ice Bucket Challenge are responsible for expediting the timeline of a clinical drug trial by two years.

ALS Trial Navigator Offers People Living with ALS an Easy Way to Search Eligible Research Studies REDLANDS, Calif., June 21, 2024--(BUSINESS WIRE)--The ALS Therapy Development Institute (ALS TDI), a ...

The ALS Therapy Development Institute has announced that it has signed a research and development agreement with Aptagen LLC, of Jacobus, Penn. Under the terms of the contract, Aptagen will apply its ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Robert Sepucha Jr. is senior vice president, policy and business development for Fresenius Medical Care North America. Prior to joining Fresenius, Sepucha served as general counsel for the ...